Article info

Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial

Authors

  1. Correpondence to Dr Evelyn Shaw; eshawp{at}gmail.com
View Full Text

Citation

Shaw E, Miró JM, Puig-Asensio M on behalf of the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III, Madrid, Spain, and GEIH (Hospital Infection Study Group), et al
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial

Publication history

  • Received September 25, 2014
  • Revised November 27, 2014
  • Accepted December 18, 2014
  • First published March 11, 2015.
Online issue publication 
March 11, 2015
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.